These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8844811

  • 21. Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity.
    Sinha R, Rothman N, Mark SD, Murray S, Brown ED, Levander OA, Davies DS, Lang NP, Kadlubar FF, Hoover RN.
    Carcinogenesis; 1995 Nov; 16(11):2859-61. PubMed ID: 7586210
    [Abstract] [Full Text] [Related]

  • 22. Metabolism of the food-derived carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in nonhuman primates.
    Snyderwine EG, Welti DH, Davis CD, Fay LB, Turesky RJ.
    Carcinogenesis; 1995 Jun; 16(6):1377-84. PubMed ID: 7788858
    [Abstract] [Full Text] [Related]

  • 23. Nitric oxide-mediated nitrosation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline potentiated by hemin and myeloperoxidase.
    Lakshmi VM, Hsu FF, Zenser TV.
    Chem Res Toxicol; 2005 Jun; 18(6):1038-47. PubMed ID: 15962939
    [Abstract] [Full Text] [Related]

  • 24. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
    Turesky RJ, Constable A, Richoz J, Varga N, Markovic J, Martin MV, Guengerich FP.
    Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
    [Abstract] [Full Text] [Related]

  • 25. Biomonitoring of heterocyclic aromatic amine metabolites in human urine.
    Stillwell WG, Turesky RJ, Sinha R, Skipper PL, Tannenbaum SR.
    Cancer Lett; 1999 Sep 01; 143(2):145-8. PubMed ID: 10503894
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo-[4,5-f]quinoline and 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring.
    Turesky RJ, Stillwell WG, Skipper PL, Tannenbaum SR.
    Environ Health Perspect; 1993 Mar 01; 99():123-8. PubMed ID: 8319609
    [Abstract] [Full Text] [Related]

  • 29. Urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in White, African-American, and Asian-American men in Los Angeles County.
    Kidd LC, Stillwell WG, Yu MC, Wishnok JS, Skipper PL, Ross RK, Henderson BE, Tannenbaum SR.
    Cancer Epidemiol Biomarkers Prev; 1999 May 01; 8(5):439-45. PubMed ID: 10350440
    [Abstract] [Full Text] [Related]

  • 30. N-hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver.
    Rich KJ, Murray BP, Lewis I, Rendell NB, Davies DS, Gooderham NJ, Boobis AR.
    Carcinogenesis; 1992 Dec 01; 13(12):2221-6. PubMed ID: 1473228
    [Abstract] [Full Text] [Related]

  • 31. Synthetic routes to the food carcinogen 2 amino-3,8-dimethylimidazo[4,5-f]quinoxaline (8-MeIQx) and related compounds.
    Grivas S.
    Princess Takamatsu Symp; 1995 Dec 01; 23():1-8. PubMed ID: 8844790
    [Abstract] [Full Text] [Related]

  • 32. Chemical methods for assessing systemic exposure to dietary heterocyclic amines in man.
    Davies DS, Gooderham NJ, Murray S, Lynch A, de la Torre R, Segura J, Boobis AR.
    Arch Toxicol Suppl; 1996 Dec 01; 18():251-8. PubMed ID: 8678801
    [Abstract] [Full Text] [Related]

  • 33. Disposition of the Dietary Mutagen 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline in Healthy and Pancreatic Cancer Compromised Humans.
    Malfatti MA, Kuhn EA, Turteltaub KW, Vickers SM, Jensen EH, Strayer L, Anderson KE.
    Chem Res Toxicol; 2016 Mar 21; 29(3):352-8. PubMed ID: 26918625
    [Abstract] [Full Text] [Related]

  • 34. Quantitation of carcinogenic heterocyclic aromatic amines and detection of novel heterocyclic aromatic amines in cooked meats and grill scrapings by HPLC/ESI-MS.
    Turesky RJ, Taylor J, Schnackenberg L, Freeman JP, Holland RD.
    J Agric Food Chem; 2005 Apr 20; 53(8):3248-58. PubMed ID: 15826085
    [Abstract] [Full Text] [Related]

  • 35. Enzymatic studies of the activation of heterocyclic food mutagens in man.
    Boobis AR, Gooderham NJ, Rich KJ, Zhao K, Edwards RJ, Murray BP, Lynch AM, Murray S, Davies DS.
    Princess Takamatsu Symp; 1995 Apr 20; 23():134-44. PubMed ID: 8844804
    [Abstract] [Full Text] [Related]

  • 36. Major routes of metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in the rat.
    Turesky RJ, Aeschbacher HU, Würzner HP, Skipper PL, Tannenbaum SR.
    Carcinogenesis; 1988 Jun 20; 9(6):1043-8. PubMed ID: 3370749
    [Abstract] [Full Text] [Related]

  • 37. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.
    Dingley KH, Freeman SP, Nelson DO, Garner RC, Turteltaub KW.
    Drug Metab Dispos; 1998 Aug 20; 26(8):825-8. PubMed ID: 9698300
    [Abstract] [Full Text] [Related]

  • 38. Dose-response studies of MeIQx in rat liver and liver DNA at low doses.
    Frantz CE, Bangerter C, Fultz E, Mayer KM, Vogel JS, Turteltaub KW.
    Carcinogenesis; 1995 Feb 20; 16(2):367-73. PubMed ID: 7859370
    [Abstract] [Full Text] [Related]

  • 39. Metabolism and biodisposition of heterocyclic amines.
    Turesky RJ.
    Prog Clin Biol Res; 1990 Feb 20; 347():39-53. PubMed ID: 2217401
    [Abstract] [Full Text] [Related]

  • 40. Immunoaffinity purification of dietary heterocyclic amine carcinogens.
    Vanderlaan M, Hwang M, Djanegara T.
    Environ Health Perspect; 1993 Mar 20; 99():285-7. PubMed ID: 8319645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.